MAPT and Cognitive impairment: Notably, MTBR-tau243 and pT205/T205 were also the optimal combination for predicting a cognitive measure (MMSE), suggesting potential clinical applications of this biomarker combination in predicting not only tau pathology but also cognitive impairment.